Interestingly, it was previously reported in gliomas that JNK may function as a positive regulator of MMP2 activity, not by interfering with the MMP expression but by the regulation of TIMP2 expression, an activator of the pro-MMP2 [41]. The gene discussed is MMP2; the disease is glioma.